Latest Biotechnology, Pharmaceutical and Healthcare News - Page: 5 from PharmaBiz

21:53 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "PharmaBiz" found in our extensive news archives from over 250 global news sources.

More Information about PharmaBiz on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PharmaBiz for you to read. Along with our medical data and news we also list PharmaBiz Clinical Trials, which are updated daily. BioPortfolio also has a large database of PharmaBiz Companies for you to search.

Showing News Articles 101–125 of 959 from PharmaBiz

Wednesday 9th January 2019

Daiichi Sankyo gets Japanese marketing nod for Tarlige tablets to treat peripheral neuropathic pain

Daiichi Sankyo announced the receipt of marketing approval in Japan for Tarlige tablets 2.5 mg, 5 mg, 10 mg, 15 mg for the treatment of peripheral neuropathic pain (PNP).

VBRI sees network of medical sensory devices to facilitate virtual and remote clinics

Vinoba Bhave Research Institute (VBRI) sees that network of medical sensory devices will facilitate virtual and remote clinics for accurate treatment. It will also build a SaaS/PaaS model to fully utilize the

Tuesday 8th January 2019

CPhI & P─MEC China 2019 to be held in Shanghai from June 18─20

CPhI & P─MEC China 2019, the most comprehensive pharmaceutical exhibition in Asia covering the entire industry chain, will be held at SNIEC, Shanghai from June 18─20, 2019. The annual pharma gala are expected to

MobileHelp, LifePod Solutions introduce AI─driven, voice─enhanced caregiving solution with emergency response functionality

MobileHelp, a leader in mobile Personal Emergency Response Systems (mPERS) and healthcare solutions, and LifePod Solutions, will be unveiling a proactive voice service enhanced with emergency response,

Vifor Pharma announces positive phase I trial results for oral ferroportin inhibitor

Vifor Pharma, a global pharmaceutical company focused in iron deficiency, nephrology and cardio─renal therapies, reported positive phase─I trial results for its oral ferroportin inhibitor. The trial which was

Vital Therapies to buy German─based clinical─stage biotech company, Immunic Therapeutics

Vital Therapies, Inc., and Immunic AG (Immunic), a private clinical─stage biotechnology company in Planegg─Martinsried, Germany, announced that they have entered into a definitive agreement under which Vital

Indian pharma companies grab 290 final ANDA approvals from US FDA in 2018

Indian Pharmaceutical companies and their subsidiaries have established strong presence in US during last couple of years with higher ANDA approvals. The loss of patent exclusivity and cost cutting measures


More than four decades after releasing the national list of essential medicines, India has now drafted the first national essential diagnostics list which is a country─specific set of tests for detecting common morbid conditions and priority diseases in the country.

Indian healthcare needs a mix of local and imported medical devices for improved patient outcomes: Chris Kamolins

Indian healthcare requires a combination of local and imported medical devices for improved patient outcomes. The sector is in an exciting phase of development. The increasing regulations will enable Indians receive

Monday 7th January 2019

US FDA grants fast track designation to CRISPR & Vertex's CTX001 to treat sickle cell disease

CRISPR Therapeutics and Vertex Pharmaceuticals Incorporated announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation for CTX001 for the treatment of sickle cell

Inclusion of medical device industry in DTAB panel on compensation a step in right direction, says MTaI

Medical Technology Association of India (MTaI), which represents leading research─based medical technology companies, said the formation of the Drugs Technical Advisory Board (DTAB)

ICRA positive on hospital sector performance

The hospital sector witnessed challenging times in 2018 with various regulatory restrictions from multiple authorities, affecting the average revenue per occupied bed day (ARPOB) of the players.

Doctor of Pharmacy Association seeks PM's intervention to incorporate Pharm D profession in NMC Bill

Urging immediate attention of the state and central governments to address the various problems faced by the Pharm D professionals in the country, the Doctor of Pharmacy Association has recently written to Prime Minister Narendra Modi

Saturday 5th January 2019

ProBioGen receives undisclosed milestone payment from Merus on use of GlymaxX ADCC enhancement technology in MCLA─129

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announced that the company achieved an undisclosed milestone payment from Merus N.V based on Merus'

International Hologram Manufacturers Association appoints Dr Paul Dunn as chairman

The International Hologram Manufacturers Association (IHMA), which represents the global hologram industry, has appointed a new chairman and board.

BioPhotas expands Celluma Series of Light Therapy Devices product

BioPhotas, Inc., the market leader in therapeutic LED Light Therapy devices, announced a major product line extension to the company's Celluma Series of Light Therapy Devices.

Merck to license investigational insulin sensitizer, NGM313 from NGM Bio to treat NASH and type 2 diabetes

Merck known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) announced that Merck has exercised its option to license NGM313, an investigational monoclonal antibody

Biogen starts phase 3b study to evaluate EID with natalizumab in multiple sclerosis

Biogen Inc. announced that the first patient has been enrolled in a global phase 3b study evaluating the efficacy and safety of extended interval dosing (EID; every six weeks) for natalizumab compared to standard

Maha FDA files 3 more FIRs against unscrupulous drug dealers for trading immunoglobulin injections in open market

In its ongoing crackdown on unscrupulous drug dealers for trading immunoglobulin injections in the open market, the Maharshtra Food and Drug Administration (FDA) has filed FIRs against 3 more persons for violation of sections 420

Friday 4th January 2019

Merck's Keytruda gets 5 new approvals from Japan PMDA

Merck, known as MSD outside the United States and Canada, announced that Keytruda, Merck's anti─PD─1 therapy, has simultaneously received five new approvals from the Japan Pharmaceuticals and Medical Devices

NPPA notification dated December 21, 2o018 fixing/revising ceiling prices/retail prices of 24 formulations under Drugs (Prices Control) Order, 2013

NPPA notification dated December 21, 2o018 fixing/revising ceiling prices/retail prices of 24 formulations under Drugs (Prices Control) Order, 2013

BrainScope gets US FDA clearance for multi─modal, multi─parameter concussion assessment

BrainScope, a medical neuro─technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, has received FDA clearance to include additional language in its product's Indications

Korea Pharma to commercialise Norgine's Plenvu in Republic of Korea

Norgine B V (Norgine), a leading European specialist pharmaceutical company and Korea Pharma Co Ltd. (Korea Pharma), a premier pharmaceutical manufacturer in Korea, announced an exclusive licence

Gujarat FDCA detects case of spurious herbal drug in circulation in Vadodara, Ahmedabad to treat joint pain

In yet another major crackdown on spurious drugs, the Gujarat Food and Drug Control Administration (FDCA) has detected a herbal drug manufacturer──Babaji Herbal Company based in Punjab for supplying

Thursday 3rd January 2019

Scientus Pharma gets Health Canada approval for sale of dried cannabis for medical purposes

HydRx Farms Ltd (o/a Scientus Pharma), a biopharmaceutical company conducting research and product development for extracts and formulations related to medical cannabinoids and their derivatives, has

Quick Search


News Quicklinks